These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25814253)

  • 1. Cardiovascular pharmacotherapy: Innovation stuck in translation.
    Rongen GA; Wever KE
    Eur J Pharmacol; 2015 Jul; 759():200-4. PubMed ID: 25814253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The translational value of non-human primates in preclinical research on infection and immunopathology.
    't Hart BA; Bogers WM; Haanstra KG; Verreck FA; Kocken CH
    Eur J Pharmacol; 2015 Jul; 759():69-83. PubMed ID: 25814254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse translation of failed treatments can help improving the validity of preclinical animal models.
    't Hart BA
    Eur J Pharmacol; 2015 Jul; 759():14-8. PubMed ID: 25823810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why So Few New Cardiovascular Drugs Translate to the Clinics.
    Vatner SF
    Circ Res; 2016 Sep; 119(6):714-7. PubMed ID: 27587410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
    Cavagnaro J; Silva Lima B
    Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in the Development of Novel Cardiovascular Therapies.
    Hwang TJ; Kesselheim AS
    Clin Pharmacol Ther; 2017 Aug; 102(2):194-196. PubMed ID: 28643861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent models for human diseases.
    Vandamme TF
    Eur J Pharmacol; 2015 Jul; 759():84-9. PubMed ID: 25823811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational In Vivo Models for Cardiovascular Diseases.
    Fliegner D; Gerdes C; Meding J; Stasch JP
    Handb Exp Pharmacol; 2016; 232():223-34. PubMed ID: 26552402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research Translation.
    Ramirez FD; Motazedian P; Jung RG; Di Santo P; MacDonald ZD; Moreland R; Simard T; Clancy AA; Russo JJ; Welch VA; Wells GA; Hibbert B
    Circ Res; 2017 Jun; 120(12):1916-1926. PubMed ID: 28373349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational research challenges: finding the right animal models.
    Prabhakar S
    J Investig Med; 2012 Dec; 60(8):1141-6. PubMed ID: 23072902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety, efficacy and regulatory triangle in drug development: Impact for animal models and the use of animals.
    van Meer PJ; Graham ML; Schuurman HJ
    Eur J Pharmacol; 2015 Jul; 759():3-13. PubMed ID: 25818943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why clinical translation cannot succeed without failure.
    London AJ; Kimmelman J
    Elife; 2015 Nov; 4():e12844. PubMed ID: 26599839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke.
    Bath PM; Macleod MR; Green AR
    Int J Stroke; 2009 Dec; 4(6):471-9. PubMed ID: 19930059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic implications of the gender-specific aspects of cardiovascular disease.
    Regitz-Zagrosek V
    Nat Rev Drug Discov; 2006 May; 5(5):425-38. PubMed ID: 16672926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preclinical research. Seal of approval translational medicine].
    Hermann S; Pichler B; Kotzerke J
    Nuklearmedizin; 2013 Dec; 52(6):N53-4. PubMed ID: 24337015
    [No Abstract]   [Full Text] [Related]  

  • 16. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail.
    Pound P; Ritskes-Hoitinga M
    J Transl Med; 2018 Nov; 16(1):304. PubMed ID: 30404629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapies.
    't Hart BA; Jagessar SA; Kap YS; Haanstra KG; Philippens IH; Serguera C; Langermans J; Vierboom M
    Drug Discov Today; 2014 Sep; 19(9):1394-401. PubMed ID: 24704460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An analysis of pharmacotherapy in an internal medicine ambulatory care clinic, using the example of cardiovascular-effective drugs].
    Conen D; Zschokke U; Dubach UC
    Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1163-8. PubMed ID: 7280625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of Huntington's disease for translation to the clinic: best practices.
    Menalled L; Brunner D
    Mov Disord; 2014 Sep; 29(11):1375-90. PubMed ID: 25216369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concordance between nonclinical and phase I clinical cardiovascular assessment from a cross-company data sharing initiative.
    Ewart L; Aylott M; Deurinck M; Engwall M; Gallacher DJ; Geys H; Jarvis P; Ju H; Leishman D; Leong L; McMahon N; Mead A; Milliken P; Suter W; Teisman A; Van Ammel K; Vargas HM; Wallis R; Valentin JP
    Toxicol Sci; 2014 Dec; 142(2):427-35. PubMed ID: 25246669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.